 <h1>Optiray 240 Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ioversol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ioversol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Optiray 240.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ioversol: injection solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Injection route (Solution)</p><p>Not for intrathecal useInadvertent intrathecal administration may cause death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ioversol (the active ingredient contained in Optiray 240) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking ioversol:</p><p>
<i>Rare</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>blood in the stools or urine</li>
<li>blue lips and fingernails</li>
<li>blurred vision</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>bruising</li>
<li>changes in skin color</li>
<li>chest pain or discomfort</li>
<li>chest tightness or heaviness</li>
<li>confusion</li>
<li>coughing</li>
<li>coughing or vomiting blood</li>
<li>coughing that sometimes produces a pink frothy sputum</li>
<li>decrease in the frequency of urination</li>
<li>decrease in urine volume</li>
<li>difficult, fast, noisy breathing</li>
<li>difficulty in passing urine (dribbling)</li>
<li>difficulty with swallowing</li>
<li>dizziness or lightheadedness</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>fainting</li>
<li>feeling of constant movement of self or surroundings</li>
<li>headache</li>
<li>hives or welts, itching, or skin rash</li>
<li>hoarseness</li>
<li>increased sweating</li>
<li>nausea</li>
<li>nervousness</li>
<li>painful urination</li>
<li>pains in the chest, groin, or legs, especially calves of the legs</li>
<li>pain, tenderness, or swelling of the foot or leg</li>
<li>pale skin</li>
<li>persistent bleeding or oozing from the puncture sites, mouth, or nose</li>
<li>pounding in the ears</li>
<li>rapid weight gain</li>
<li>redness of the skin</li>
<li>seizures</li>
<li>sensation of spinning</li>
<li>severe headaches of sudden onset</li>
<li>severe numbness, especially on one side of the face or body</li>
<li>severe, unusual tiredness or weakness</li>
<li>slow, fast, or irregular heartbeat</li>
<li>slow or irregular breathing</li>
<li>stupor</li>
<li>sudden loss of coordination</li>
<li>sudden onset of shortness of breath for no apparent reason</li>
<li>sudden onset of slurred speech</li>
<li>sudden vision changes</li>
<li>sweating</li>
<li>swelling around the eyes</li>
<li>swelling in the legs and ankles</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>chills</li>
<li>coma</li>
<li>confusion</li>
<li>depression</li>
<li>diarrhea</li>
<li>extremely high fever or body temperature</li>
<li>fast, shallow breathing</li>
<li>fast, weak heartbeat</li>
<li>fever</li>
<li>hostility</li>
<li>irritability</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>lethargy</li>
<li>muscle cramps</li>
<li>muscle twitching</li>
<li>no sensation in the legs</li>
<li>not able to pass urine</li>
<li>pale, clammy skin</li>
<li>red, irritated eyes</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area</li>
<li>thirst</li>
<li>unable to move the legs</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ioversol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common or rare</i>
</p><ul>
<li>Bad taste</li>
<li>collection of blood under the skin</li>
<li>deep, dark purple bruise</li>
<li>dry mouth</li>
<li>pain, redness, or pale skin at the injection site</li>
<li>ringing in the ears</li>
<li>vomiting</li>
</ul><p>
<!-- end injection solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ioversol: injectable solution</i></p><h3>General</h3><p>Adverse reactions following the use of this drug are generally independent of the dose and usually mild to moderate, of short duration and resolve spontaneously (without treatment).</p>
<p>The most frequently reported adverse reactions were mild discomfort, heat or cold sensation, pain during the injection, transient test perversion, nausea, vomiting, skin reactions such as and urticaria or erythema.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Feeling hot</p>
<p><b>Common</b> (1% to 10%): Pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Vertigo, extravasation, shaking, chills, fever, feeling cold</p>
<p><b>Very rare</b> (less than 0.01%): Tinnitus, edema, malaise, tiredness, sluggishness, feeling abnormal</p>
<p><b>Frequency not reported</b>: Hyperthermia, pyrexia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea</p>
<p><b>Uncommon</b> (0.1% to 1%): Vomiting, dry mouth</p>
<p><b>Very rare</b> (less than 0.01%): Sialoadenitis, abdominal pain, tongue edema, dysphagia, hypersalivation</p>
<p><b>Frequency not reported</b>: Diarrhea<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Cerebral infarct, lightheadedness, vasovagal reaction, disorientation, paresthesia, dysphasia, visual hallucinations, syncope, bad taste</p>
<p><b>Rare</b> (0.01% to 0.1%): Dizziness, dysgeusia, tremor, convulsions, aphasia, paralysis, coma and death</p>
<p><b>Very rare</b> (less than 0.01%): Loss of consciousness, speech disorder, somnolence, hypoesthesia, stupor</p>
<p><b>Frequency not reported</b>: Dyskinesia, amnesia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Angina pectoris, hypotension, blood pressure fluctuation, arterial spasm, bradycardia, conduction defect, false aneurysm, hypertension, transient, arrhythmia, vascular trauma, hematoma</p>
<p><b>Rare</b> (less than 0.1%): Arterial thrombosis, displacement of arterial plaques, venous thrombosis, dissection of the coronary vessels, transient sinus arrest, thrombophlebitis, flushing</p>
<p><b>Very rare</b> (less than 0.01%): Heart block, abnormal ECG, atrial fibrillation, cerebrovascular disorder</p>
<p><b>Frequency not reported</b>: Tachycardia; T-wave amplitude; ST depression, ST elevation; changes in cardiac output, left ventricular systolic and end-diastolic pressure, right ventricular systolic and pulmonary artery systolic pressure; decreases in systolic and diastolic blood pressure; myocardial infarction; angioneurotic edema, peripheral edema, vasodilation, thrombosis, disseminated intravascular coagulation, shock, cyanosis, extrasystole, palpitations, vasospasm<sup>[Ref]</sup></p><p>Regardless of the contrast medium employed, the overall incidence of serious adverse reaction is higher with coronary arteriography than with other procedures.  Cardiac decompensation, serious arrhythmias, myocardial ischemia, or myocardial infarction may occur during coronary arteriography and left ventriculography.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Urticaria, pruritus, facial edema, erythema</p>
<p><b>Rare</b> (0.01% to 0.1%): Rash</p>
<p><b>Very rare</b> (less than 0.01%): Angioedema, hyperhidrosis (including cold sweat)</p>
<p><b>Frequency not reported</b>: Maculopapular rash, ecchymosis, tissue necrosis, toxic epidermal necrolysis, acute generalized erythematous pustulosis, erythema multiforme, pallor<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Polyuria, urinary retention</p>
<p><b>Very rare</b> (less than 0.01%): Incontinence, hematuria</p>
<p><b>Frequency not reported</b>: Temporary anuria, dysuria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision, periorbital edema</p>
<p><b>Very rare</b> (less than 0.01%): Allergic conjunctivitis (including eye irritation, ocular hyperemia, watery eyes, swelling of conjunctiva, etc.)</p>
<p><b>Frequency not reported</b>: Transient blindness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Laryngeal edema, pulmonary edema, sneezing, congestion, coughing, shortness of breath, hypoxia</p>
<p><b>Rare</b> (0.01% to 0.1%): Laryngeal spasm and obstruction (including throat tightness, stridor, etc.), dyspnea, rhinitis, throat irritation</p>
<p><b>Very rare</b> (less than 0.01%): Pharyngitis</p>
<p><b>Frequency not reported</b>: Brachial plexus palsy following auxiliary artery injections, chest pain, choking, wheezing (may be an initial manifestation of more severe and infrequent reactions including asthmatic attack), bronchospasm, apnea, respiratory arrest, asthma, dysphonia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylaxis with loss of consciousness, coma, severe cardiovascular disturbances and death</p>
<p><b>Very rare</b> (less than 0.01%): Anaphylactoid reactions<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Muscle spasm<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very rare</b> (less than 0.01%): injection site reactions (including pain, erythema, and hemorrhage up to necrosis especially after extravasation)</p>
<p><b>Frequency not reported</b>: Hemorrhage or pseudoaneurysms at the puncture site<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very rare</b> (less than 0.01%): Agitation, anxiety, confusion<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Acute renal failure, abnormal renal function, decreased creatinine clearance, increased BUN</p>
<p><b>Frequency not reported</b>: Temporary nephropathy, renal colic<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Thyroid function tests indicative of hypothyroidism or transient thyroid suppression in adult and pediatric patients (including infants)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Transient changes in hepatorenal chemistry tests<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Optiray 350 (ioversol)." Mallinckrodt Medical Inc, St. Louis, MO. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Optiray 240 (ioversol)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: non-ionic iodinated contrast media</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Optiray 240 &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Optiray 350, Optiray 160, Optiray 300, Optiray 320</dd></dl>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Body Imaging</li>
<li>Cerebral Arteriography</li>
<li>Coronary Arteriography</li>
<li>Head Imaging</li>
<li data-more-config-id="list-data-resources-conditions">... +9 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ioversol: injectable solution</i></p><h3>General</h3><p>Adverse reactions following the use of this drug are generally independent of the dose and usually mild to moderate, of short duration and resolve spontaneously (without treatment).</p><p>The most frequently reported adverse reactions were mild discomfort, heat or cold sensation, pain during the injection, transient test perversion, nausea, vomiting, skin reactions such as and urticaria or erythema.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Feeling hot</p><p><b>Common</b> (1% to 10%): Pain</p><p><b>Uncommon</b> (0.1% to 1%): Vertigo, extravasation, shaking, chills, fever, feeling cold</p><p><b>Very rare</b> (less than 0.01%): Tinnitus, edema, malaise, tiredness, sluggishness, feeling abnormal</p><p><b>Frequency not reported</b>: Hyperthermia, pyrexia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea</p><p><b>Uncommon</b> (0.1% to 1%): Vomiting, dry mouth</p><p><b>Very rare</b> (less than 0.01%): Sialoadenitis, abdominal pain, tongue edema, dysphagia, hypersalivation</p><p><b>Frequency not reported</b>: Diarrhea<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Uncommon</b> (0.1% to 1%): Cerebral infarct, lightheadedness, vasovagal reaction, disorientation, paresthesia, dysphasia, visual hallucinations, syncope, bad taste</p><p><b>Rare</b> (0.01% to 0.1%): Dizziness, dysgeusia, tremor, convulsions, aphasia, paralysis, coma and death</p><p><b>Very rare</b> (less than 0.01%): Loss of consciousness, speech disorder, somnolence, hypoesthesia, stupor</p><p><b>Frequency not reported</b>: Dyskinesia, amnesia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Angina pectoris, hypotension, blood pressure fluctuation, arterial spasm, bradycardia, conduction defect, false aneurysm, hypertension, transient, arrhythmia, vascular trauma, hematoma</p><p><b>Rare</b> (less than 0.1%): Arterial thrombosis, displacement of arterial plaques, venous thrombosis, dissection of the coronary vessels, transient sinus arrest, thrombophlebitis, flushing</p><p><b>Very rare</b> (less than 0.01%): Heart block, abnormal ECG, atrial fibrillation, cerebrovascular disorder</p><p><b>Frequency not reported</b>: Tachycardia; T-wave amplitude; ST depression, ST elevation; changes in cardiac output, left ventricular systolic and end-diastolic pressure, right ventricular systolic and pulmonary artery systolic pressure; decreases in systolic and diastolic blood pressure; myocardial infarction; angioneurotic edema, peripheral edema, vasodilation, thrombosis, disseminated intravascular coagulation, shock, cyanosis, extrasystole, palpitations, vasospasm<sup>[Ref]</sup></p><p>Regardless of the contrast medium employed, the overall incidence of serious adverse reaction is higher with coronary arteriography than with other procedures.  Cardiac decompensation, serious arrhythmias, myocardial ischemia, or myocardial infarction may occur during coronary arteriography and left ventriculography.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Urticaria, pruritus, facial edema, erythema</p><p><b>Rare</b> (0.01% to 0.1%): Rash</p><p><b>Very rare</b> (less than 0.01%): Angioedema, hyperhidrosis (including cold sweat)</p><p><b>Frequency not reported</b>: Maculopapular rash, ecchymosis, tissue necrosis, toxic epidermal necrolysis, acute generalized erythematous pustulosis, erythema multiforme, pallor<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Polyuria, urinary retention</p><p><b>Very rare</b> (less than 0.01%): Incontinence, hematuria</p><p><b>Frequency not reported</b>: Temporary anuria, dysuria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision, periorbital edema</p><p><b>Very rare</b> (less than 0.01%): Allergic conjunctivitis (including eye irritation, ocular hyperemia, watery eyes, swelling of conjunctiva, etc.)</p><p><b>Frequency not reported</b>: Transient blindness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Laryngeal edema, pulmonary edema, sneezing, congestion, coughing, shortness of breath, hypoxia</p><p><b>Rare</b> (0.01% to 0.1%): Laryngeal spasm and obstruction (including throat tightness, stridor, etc.), dyspnea, rhinitis, throat irritation</p><p><b>Very rare</b> (less than 0.01%): Pharyngitis</p><p><b>Frequency not reported</b>: Brachial plexus palsy following auxiliary artery injections, chest pain, choking, wheezing (may be an initial manifestation of more severe and infrequent reactions including asthmatic attack), bronchospasm, apnea, respiratory arrest, asthma, dysphonia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylaxis with loss of consciousness, coma, severe cardiovascular disturbances and death</p><p><b>Very rare</b> (less than 0.01%): Anaphylactoid reactions<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Muscle spasm<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very rare</b> (less than 0.01%): injection site reactions (including pain, erythema, and hemorrhage up to necrosis especially after extravasation)</p><p><b>Frequency not reported</b>: Hemorrhage or pseudoaneurysms at the puncture site<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very rare</b> (less than 0.01%): Agitation, anxiety, confusion<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Acute renal failure, abnormal renal function, decreased creatinine clearance, increased BUN</p><p><b>Frequency not reported</b>: Temporary nephropathy, renal colic<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Thyroid function tests indicative of hypothyroidism or transient thyroid suppression in adult and pediatric patients (including infants)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Transient changes in hepatorenal chemistry tests<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Optiray 350 (ioversol)." Mallinckrodt Medical Inc, St. Louis, MO. </p><h2>More about Optiray 240 (ioversol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: non-ionic iodinated contrast media</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Optiray 240 &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Body Imaging</li>
<li>Cerebral Arteriography</li>
<li>Coronary Arteriography</li>
<li>Head Imaging</li>
<li data-more-config-id="list-data-resources-conditions">... +9 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>